These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12771291

  • 1. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii9-12. PubMed ID: 12771291
    [Abstract] [Full Text] [Related]

  • 2. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 3. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
    Buchwald PC, Akerström G, Westin G.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 5. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
    Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R.
    Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
    [Abstract] [Full Text] [Related]

  • 6. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract] [Full Text] [Related]

  • 7. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 8. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T, Rastad J, Szabó E, Westin G, Akerström G.
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [Abstract] [Full Text] [Related]

  • 9. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.
    Kidney Blood Press Res; 2013 May; 37(1):84-94. PubMed ID: 23552627
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [Abstract] [Full Text] [Related]

  • 12. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 13. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.
    Taniguchi M, Tokumoto M, Matsuo D, Motoyama K, Sugitani A, Kuroki S, Yotsueda H, Tsuruya K, Hirakata H, Iida M.
    Kidney Int; 2006 Jul 01; 70(2):363-70. PubMed ID: 16738533
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
    Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP.
    Genes Dev; 1996 Jan 15; 10(2):142-53. PubMed ID: 8566748
    [Abstract] [Full Text] [Related]

  • 15. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN, Kayath MJ, Vieira JG, Nosé-Alberti V.
    Histopathology; 1998 Jul 15; 33(1):46-51. PubMed ID: 9726048
    [Abstract] [Full Text] [Related]

  • 16. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
    Rodriguez ME, Almaden Y, Cañadillas S, Canalejo A, Siendones E, Lopez I, Aguilera-Tejero E, Martin D, Rodriguez M.
    Am J Physiol Renal Physiol; 2007 May 15; 292(5):F1390-5. PubMed ID: 17200160
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
    Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T, Kazuharu Uchida (Yagoto PTx Forum).
    Ther Apher Dial; 2007 Aug 15; 11(4):266-73. PubMed ID: 17661832
    [Abstract] [Full Text] [Related]

  • 18. 22-Oxacalcitriol upregulates p21(WAF1/Cip1) in human parathyroid glands. A preliminary report.
    Shiraishi K, Tsuchida M, Wada T, Yoshihiro S, Takai K, Suga A, Kaneda Y, Naito K.
    Am J Nephrol; 2001 Aug 15; 21(6):507-11. PubMed ID: 11799271
    [Abstract] [Full Text] [Related]

  • 19. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.
    Srivastava T, Garola RE, Whiting JM, Alon US.
    Kidney Int; 2003 Apr 15; 63(4):1374-81. PubMed ID: 12631353
    [Abstract] [Full Text] [Related]

  • 20. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
    Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Tokumoto M, Gonzalez-Suarez I, Lu Y, Tominaga Y, Cannata-Andia J, Slatopolsky E, Dusso AS.
    J Am Soc Nephrol; 2008 Feb 15; 19(2):310-20. PubMed ID: 18216322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.